| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |